Moderna (MRNA) Stock Falls 24% After Cancer-Vaccine Surge
· financefeeds.com
Moderna (MRNA) fell 24% Thursday, giving back part of its cancer-vaccine surge. Why the rally faded and the October catalyst that decides what happens next
Moderna (MRNA) Gave Back a Quarter of Its Cancer-Vaccine Surge, Here’s What Wall Street Is Waiting For
Moderna (NASDAQ: MRNA) gave back a large piece of its ...